Ignite Creation Date:
2025-12-25 @ 4:18 AM
Ignite Modification Date:
2026-02-28 @ 5:33 AM
Study NCT ID:
NCT00667420
Status:
TERMINATED
Last Update Posted:
2014-07-04
First Post:
2008-04-24
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Perioperative Panitumumab and Epirubicin, Oxaliplatin and Xeloda (EOX) in Patients With Gastroesophageal Adenocarcinoma
Sponsor:
Massachusetts General Hospital
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2008-04
Start Date Type:
None
Primary Completion Date:
2011-06
Primary Completion Date Type:
ACTUAL
Completion Date:
2014-06
Completion Date Type:
ACTUAL
First Submit Date:
2008-04-24
First Submit QC Date:
None
Study First Post Date:
2008-04-28
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2014-06-27
Results First Submit QC Date:
None
Results First Post Date:
2014-07-04
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2014-07-03
Last Update Post Date:
2014-07-04
Last Update Post Date Type:
ESTIMATED